Oncodea
Health Care
Overview
Home » Our Mission Every year, over 1.6 million Americans and 17 million world citizens are diagnosed with cancer according to the American Cancer Society. The effect of diagnosing cancer earlier and detecting recurrence sooner in those at high risk and cancer patients and survivors is enormous.
Funding and backers
Backers
1
Plug and Play
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
C the Signs is an MHRA Class I medical device helping GPs detect and refer patients at risk of cancer earlier, when survival is highest.
There are approximately 60 million Americans suffering from sleep disorders - most of whom are undiagnosed. As professionals in the…
Cairn Therapeutics: Targeting the Cancer, just the cancer. Making cancer treatment simpler and safer with CT-262.
Supporting cancer patients in their hour of need.. We're on a mission to guide patients through cancer, helping them reach fantastic…
Revolutionizing cancer detection with Syantra’s Onco-ID™ platform. By analyzing shifts in the body’s systems, we detect cancer earlier and…
Qritive builds AI software that assists pathologists in diagnosing cancer from digitised tissue slides. Its systems prioritise cases and…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Plug and PlayVia a fund
2741 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely